FDA | Press Releases
Follow
FDA Grants Accelerated Approval to First Treatment for Barth Syndrome
The U.S. Food and Drug Administration granted accelerated approval to Forzinity (elamipretide) injection as the first treatment for Barth syndrome, in patients weighing at least 30 kg.
